Uric acid is considered a major antioxidant in human blood that may protect against aging and oxidative stress. Despite its proposed protective properties, elevated levels of uric acid are commonly associated with increased risk for cardiovascular disease and mortality. Furthermore, recent experimental studies suggest that uric acid may have a causal role in hypertension and metabolic syndrome. All these conditions thought to be mediated by oxidative stress. Here we demonstrate that differentiation of cultured mouse adipocytes is associated with increased production of reactive oxygen species (ROS) and uptake of uric acid. Soluble uric acid stimulated an increase in NADPH oxidase activity and ROS production in mature adipocytes but not preadipocytes, The stimulation of NADPH oxidase-dependent ROS by uric acid resulted in activation of MAP kinases p38 and Erk1/2, a decrease in nitric oxide bioavailability and increase in protein nitrosylation and lipid oxidation. Collectively, our results suggest that hyperuricemia induces redoxdependent signaling and oxidative stress in adipocytes. Since oxidative stress in the adipose tissue has recently been recognized as a major cause of insulin resistance and cardiovascular disease, hyperuricemia-induced alterations in oxidative homeostasis in the adipose tissue might play an important role in these derangements.
Introduction
Uric acid is an intermediate product of the purine degradation pathway in the cell. In most mammals, uric acid is degraded further by the enzyme uricase. In humans and Great Apes the uricase gene was inactivated during hominoid evolution (44) , and uric acid is the final metabolic product of purine catabolism. Humans are unique among mammalian species by the highest basal blood level of uric acid and by the ability to develop hyperuricemia (22) . Since the discovery in 1981 that urate is a powerful chemical antioxidant, which is present in human plasma in concentrations much higher than ascorbate (2) , it is widely accepted that high blood levels of uric acid in humans carry an evolutionary advantage, and that uric acid is a major antioxidant that protects cardiac, vascular and neural cells from oxidative injury (14, 53) .
On the other hand, hyperuricemia even without crystal deposition and gout is strongly associated with cardiovascular disease, kidney disease and hypertension increasing risk of mortality (21) . Hyperuricemia is also common in the metabolic syndrome and obesity (8, 37, 45) . Albeit there is tremendous complexity of these disorders, an unambiguous common pathogenetic feature for all of them is, paradoxically, an involvement of oxidative stress and oxidative modifications of proteins and lipids as well as redox-dependent low-grade inflammation (5, 13, 18, 53, 57) .
Oxidative stress and inflammation in the adipose tissue induce an imbalance in the production of adipocyte-specific hormones and cytokines (adipokines) that contribute substantially to the development of insulin resistance and cardiovascular risk associated with obesity (6, 13, 57) . Serum levels of uric acid are positively correlated with obesity (8, 45) , especially visceral obesity (37) . Although hyperuricemia is often considered as a secondary phenomenon in the metabolic syndrome (50) , it has also been noticed to be an independent predictor of obesity and hyperinsulinemia (42, 58) . Most importantly, it has been shown recently that uric acid has a causal role in the metabolic syndrome induced by fructose (41) . The possibility that uric acid could have a direct effect on the adipose tissue was not considered and to the best of our knowledge remains unknown.
Physiological concentrations of soluble microcrystal-free uric acid induce gene expression of chemokines and growth factors, such as MCP-1 and PDGF (24, 56) , and stimulate proliferation of vascular smooth muscle cells (VSMC) (25) . The effects of urate might involve complex and poorly understood redox-dependent pathways. Urate-induced MCP-1 expression in VSMC was attenuated by antioxidants suggesting involvement of redox-dependent mechanism (24) . Available data suggest that uric acid is not necessarily an antioxidant, and depending on the chemical milieu may become a prooxidant. On one hand, in the extracellular environment, urate can scavenge hydroxyl radical, singlet oxygen and peroxynitrite, especially when combined with ascorbic acid or thiols (1, 2, 31) . On the other hand, uric acid loses its antioxidant ability in the hydrophobic environment (40) . Moreover, it can form free radicals either alone (34) , or in combination with peroxynitrite (51) .
This study helps resolve the above paradox. We demonstrate that adipocyte differentiation is associated with increased uptake of uric acid and ROS accumulation and that elevated uric acid induced further increase in intracellular ROS production in differentiated adipocytes, mediated by activation of NADPH oxidase (NOX). It is followed by redox-dependent stress signaling, a decrease in nitric oxide bioavailability and oxidative modifications of proteins and lipids. Since oxidative stress in adipose tissue has emerged as a major cause of insulin resistance and imbalance in vascular homeostasis, hyperuricemia-induced alterations in oxidative homeostasis in adipose tissue might play a crucial role in these derangements.
Materials and Methods
Cell culture and treatments. Preadipocyte 3T3-L1 cells obtained from ATCC (Manassas, VA) were maintained in high glucose DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS and antibiotics. For differentiation, we treated confluent cells with 10 µg/ml insulin, 0.25 µM dexamethasone and 0.5 mM isobutyl-1-methylxanhine (IBMX) for 2 days followed by 3-day treatment with insulin alone. Uric acid solution for cell treatments was prepared in the prewarmed cell culture medium (Sigma, Ultrapure; 1-15 mg/dl, microcrystal-free endotoxin-free solution) and passed through 20 µm sterile filter), as previously described (24) .
Detection of ROS and NO.
We assessed intracellular ROS by several independent methods: (i) with the ROS-specific fluorescent probe 5 (and 6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate-acetyl ester (CM-H 2 DCFDA). At the end of treatments, (ii) We also measured superoxide generation using nitroblue tetrazoilium (NBT) assay (46) . Briefly, at the end of treatments, 0.2% NBT (Sigma, St. Louis, MO) was added to the medium for 1 hour, followed by washing of the cell monolayer with PBS and dissolving of water-insoluble reduced NBT (blue formazan) accumulated in cells in 50 % acetic acid. The absorbance of blue formazan was measured at 560 nm using microplate reader Bio-Tek Powerwave 200 (Bio-Tek Instruments, Winooski, VT). The contribution of the direct NBT reduction by uric acid in the culture medium to the total absorbance was negligible (about 5% at the concentration 15 mg/dl when tested in the cell-free medium). (iii) we also detected superoxide by lucigenin-enhanced chemiluminescent method (see below). (iv) We used Mn(II) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP), superoxide scavenger and a cell permeable mimetic of superoxide dismutase to distinguish superoxide form another ROS.
The intracellular level of nitric oxide was measured using NO-specific fluorescent probe 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM diacetate, 5 µM; Molecular Probes) following the same procedure as for ROS detection.
Immunofluorescence. For immunofluorescent detection of the p40phox translocation or URAT1 expression, we cultured cells on coverslips. After treatments, cells were fixed Measurement of NADPH oxidase. NADPH oxidase activity was measured by the lucigenin-enhanced chemiluminescence method in crude cell homogenates and microsomal membrane fractions following the described procedures with minor modifications (15, 54) . To prepare cell homogenates, cell monolayer was washed three times with ice-cold PBS and scraped on ice in lysis buffer containing 20 mM Kphosphate buffer, pH 7.0, 1 mM EGTA, 1 mM PMSF, 10 µg/ml aprotinin, 5 µg/ml leupeptin followed by homogenization with 100 strokes in a Dounce homogenizer on ice.
For the isolation of microsomal membranes, cell homogenates were prepared in 250 mM sucrose, 5 mM HEPES, pH 7.4, 1 mM PMSF, 10 µg/ml aprotinin, 5 µg/ml leupeptin followed by centrifugation at 1000 g (10 min, Statistics. At least three independent experiments were performed in triplicate each.
Data were analyzed by one-way ANOVA followed by Fisher's least significant test, 
Results
Increased ROS production and urate uptake are associated with the phenotype of differentiated adipocytes. We used a well-established model of 3T3-L1 mouse adipocytes (16) . 3T3-L1 cells treated with the differentiation media accumulated remarkably high level of intracellular ROS, which is barely detectable in undifferentiated cells (Fig. 1a) .
As expected, adipocyte differentiation was associated with accumulation of lipids, increased expression of the adipogenic transcription factor (PPAR-) and the adipocytespecific hormone adiponectin ( Supplementary Fig. S1 online) .
3T3-L1 adipocytes demonstrated a rapid uptake of [ 14 C]-uric acid (Fig. 1b,c) . The uptake rate in differentiated adipocytes was significantly higher than in undifferentiated cells (Fig. 1b) . Probenecid, an inhibitor of urate transport via the organic anion transporter (OAT) family including the specific urate transporter URAT1 (39), significantly attenuated urate uptake by adipocytes (Fig.1c) . RT-PCR for mouse URAT1 (Fig. 1d) and immunofluorescent detection of URAT1 (Fig. 1e) showed that differentiated adipocytes express this previously considered kidney-specific transporter with quite high intensity as compared to the kidney. URAT1 is localized in the plasma membrane (Fig 1e, arrows) and in vesicular structures in the perinuclear and plasma membrane regions (Fig 1e, arrowheads) , These data show that the mature adipocyte phenotype is associated with high level of oxidant production, expression of a uratespecific transporter and increased urate uptake.
Urate-induced production of ROS in adipocytes. Next, we determined whether the presence of soluble uric acid in the medium affects the level of ROS produced by adipocytes. Hyperuricemia in vivo is induced by a variety of causes, and can be chronic or acute (26) . In order to test long-term effects of uric acid, we incubated cells with varying concentrations of uric acid during adipocyte differentiation. To detect acute effects, uric acid was added to differentiated adipocytes for short periods of time (5-30 min). The presence of 1-15 mg/dl uric acid during the differentiation of adipocytes produced a moderate but significant increase in ROS production as determined by the NBT assay, whereas no effect of uric acid was detected in untreated undifferentiated cells or in incompletely differentiated cells (Fig. 2a) . Similar results were obtained when ROS were detected using the fluorescent probe H 2 DCFDA (Fig. 2b, c) . When differentiated adipocytes were treated with varying concentrations of uric acid for 30 min, the effect on ROS production was even more pronounced than after long-term stimulation (Fig. 2d) .
To determine whether transport of uric acid into adipocytes is required for stimulation of ROS production, we pretreated cells with probenecid and benzbromarone, two structurally unrelated OAT inhibitors of the transmembrane transport of urate (39) . As shown in Fig. 2e , both inhibitors prevented stimulation of ROS generation in adipocytes in response to uric acid suggesting that uric acid must enter the cell to induce ROS production. (Fig. 2f) demonstrating the involvement of superoxide in the urateinduced ROS generation. In addition, the effect of uric acid was completely blocked by the general antioxidant N-acetyl cysteine (10mM) as well as by apocynin (200 µM) and diphenylene-iodonium (DPI, 10µM), structurally unrelated NOX inhibitors, while rotenone (100 µM), an inhibitor of the mitochondrial electron-transport chain complex I, and thenoyltrifluoroacetone (TTFA, 100 µM), an inhibitor of the complex II, were without effect (Fig. 2g) . These data suggest that the elevation in ROS abundance in adipocytes in response to uric acid depends on superoxide generation by NADPH oxidase but not the mitochondrial respiratory chain, another major source of superoxide in the cell.
Involvement of NADPH
Next, we examined the effect of uric acid on the enzymatic activity of NADPH oxidase. With the use of lucigenin-enhanced chemiluminescent superoxide detection, we found that cellular homogenates of differentiated adipocytes are capable of NADPHdependent O 2 -• generation, which can be inhibited by apocynin or superoxide dismutase (Fig. 3a) . These data indicate the presence of active NADPH oxidase in the adipocytes.
Importantly, uric acid increased the superoxide dismutase-sensitive and apocynin-sensitive components of NADPH-dependent O 2 -• production in a dose dependent manner (Fig. 3b) . Since active NADPH oxidase is a membrane-associated enzyme (4, 7, 32), we tested the effect of uric acid on the NADPH oxidase activity in microsomal membranes.
Treatment of differentiated adipocytes with uric acid stimulated apocynin-sensitive NADPH-dependent O 2 -• generation in the microsomal fraction (Fig. 3c) .
The mechanism for the activation of NADPH oxidase-dependent ROX production depends on the nature of the particular NOX isoforms and subunits involved in the formation of the active holoenzyme (4, 7, 32) . It is known that 3T3-L1 adipocytes express NOX4 (33) . What kind of cytoplasmic regulatory subunits are expressed in these cells remains unknown, although NOX4, in contrast to other NADPH oxidases, does not require cytoplasmic proteins for its activity (35) . In order to define the isoforms of NADPH oxidase in 3T3-L1 adipocytes and better understand potential mechanism(s) of NOX activation by uric acid, we analyzed expression of mRNA for most known isoforms of the NOX family as well as cytoplasmic regulatory subunits involved in the NOX activation (Fig. 4) . Differentiated 3T3-L1 adipocytes express predominantly NOX4 (Fig.   4a) , which is in agreement with the previously published observation (33) . However, in addition to NOX4, we were able to detect NOX3 and NOX2 (gp91phox) but not NOX1 (Fig. 4a) , DUOX1 and DUOX2 (not shown). Among other proteins involved in the formation of active NADPH oxidase, we detected quite high expression of mRNAs for NOXA2 (p67phox), NOXO1 and NOXO2 (p47phox) (Fig. 4b) . Expression of mRNA for p40phox was lower than other proteins, and this mRNA could be reliably detected only after increasing the number of amplification cycles (Fig. 4c) . Surprisingly, p22phox, which is an important activator for most NOX enzymes, was also detected only after additional amplification (Fig. 4b, c) , and it was expressed at the level comparable with p40phox. Thus, 3T3-L1 adipocytes express several isoforms of NADPH oxidase: NOX4, NOX3 and NOX2 with several regulatory subunits including those involved in the formation of the classical phagocyte type NADPH oxidase (gp91phox, p67phox, p47phox, 40phox and p22phox).
The predominant mechanism of activation for many NOX isoforms is a stimulusinduced assembly of the active holoenzyme on the plasma membrane (7, 32, 52). Since we observed an expression of p47phox and p67phox, which are required for the activation of gp91phox and other NOX isoforms, and p40phox, which also might play a regulatory role, we assessed the effect of uric acid on translocation of p67phox and p40phox to the membranes. Immunoblot analysis of subcellular fractions of adipocytes treated with uric acid revealed that uric acid induced dramatic dose-dependent increase in the content of p67phox in the microsomal fraction with simultaneous decrease in the cytosol (Fig. 5a) indicating translocation of the subunit from the cytosol to membranes.
An increase of p40phox content in the microsomal fraction was also visible (Fig. 5a) .
However, immunodetection of this subunit was difficult because of the low expression.
Membrane translocation of p67phox and p40phox upon stimulation with uric acid was further confirmed by characterization of the trafficking using immunofluorescent detection followed by microscopy with optical sectioning and 3D deconvolution of the optical sections. 
Urate-induced redox-dependent activation of Erk1/2 and p38 MAP kinases is
mediated by NADPH oxidase. ROS are pivotal components of intracellular signaling pathways and regulate a variety of normal cellular functions and/or stress response mechanisms and antioxidant systems. In order to test whether urate-induced NOXdependent ROS production is involved in activation of intracellular signaling pathways, we examined the effect of uric acid on the activation of two major pathways: p38 MAP kinase and Erk1/2 MAP kinase. Uric acid rapidly induced a dramatic but transient increase in the amount of activated (phosphorylated) but not total p38 and Erk1/2 (Fig.   6a) . The activation was maximal at 5 min and decreased to basal levels after 30 min.
Similar manipulations with uric acid-free medium did not produce any changes in p38
and Erk1/2 phosphorylation (not shown) demonstrating that the activation is not a result of medium change. To test involvement of NADPH-dependent ROS, we pretreated adipocytes with N-acetyl-cysteine, MnTMPyP or apocynin prior to stimulation with uric acid. The inhibitors did not produce statistically significant changes in the phosphorylation of p38 and Erk1/2 MAPKs under basal conditions but MnTMPyP and apocynin abolished or at least significantly attenuated the effect of uric acid (Fig. 6b) .
However, the effect of N-acetyl cysteine was not statistically significant. Since N-acetyl cysteine is a precursor of glutathione, it suggests that redox-dependent activation of p38 and Erk1/2 MAP kinases by uric acid may be relatively independent of the status of the glutathione system. It has been reported previously that redox-dependent activation of MAP kinases might be glutathione (and NAC)-dependent in some cases (17) and independent in others (55) . Overall, our data demonstrate that urate-induced activation of Erk1/2 and p38 is at least partially redox-dependent and is mediated by NADPH oxidaseinduced superoxide.
NADPH-dependent decrease in NO bioavailability in adipocytes in response to uric
acid. A decrease in NO bioavailability in endothelial cells appears to play an important role in the pathway by which uric acid causes hypertension, metabolic syndrome and kidney disease in experimental models (30, 41) . eNOS and iNOS-dependent nitric oxide is abundant in adipocytes, while the biological role of NO in these cells is considered important but remains incompletely understood (12, 28) . To address the possibility of redox-dependent intracellular effects of uric acid on the NO system in adipocytes, we measured NO production in differentiated adipocytes treated with uric acid. The level of NO in differentiated adipocytes is much higher than in undifferentiated cells (Fig. 7a ).
An inhibitor of NO synthesis, N -nitro-L-arginine methyl ester (L-NAME), attenuated DAF-FM fluorescence demonstrating nitric oxide synthase-dependent NO production in adipocytes (Fig. 7b) . Long-term cell treatment with uric acid during adipocyte differentiation induced a dose-dependent decrease in NO bioavailability to levels detected in preadipocytes ( Fig. 7c and supplemental Fig. S2 ). Undifferentiated cells were not affected by treatment with uric acid (Fig. 7c) . Uric acid added to differentiated adipocytes also induced a rapid decrease in NO levels ( Fig. 7d and Supplemental Fig.   S3 ). Probenecid prevented this decrease suggesting that the effect of uric acid required its transport into the cytoplasm (Fig. 7d) . The decrease in NO bioavailability was not due to changes in eNOS activation mediated by phosphorylation of Ser1177 (Supplemental Fig.   S3 ), suggesting that the mechanism for reducing NO level is not related to the common signaling pathway for eNOS activation. The decrease in NO bioavailability in response to uric acid was attenuated by N-acetyl-cysteine and apocynin demonstrating that the effect of uric acid is mediated by oxidants and activation of NADPH oxidase (Fig. 7e) .
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Uric acid-induced oxidative modifications in adipocytes: protein nitrosylation and lipid oxidation. Given the high basal level of NO in differentiated adipocytes (Fig. 7a) , the effect of uric acid to induce a simultaneous increase in ROS production ( Fig. 2) and decrease in NO bioavailability (Fig. 7) suggested that urate-induced overproduction of ROS might result in formation of peroxynitrite as well as other reactive nitrogen species.
Once formed, these radicals can induce oxidative modifications of proteins and lipids. To test this possibility, we performed immunoblot detection of nitrosylated proteins in cell lysates obtained from adipocytes treated with uric acid using monoclonal antibody to 3-nitrotyrosine. Nitration of tyrosine serves as a well-established marker or molecular "foot-print" of reactive nitrogen species including peroxynitrite (10) . As shown in Fig.   8a , nitrosylated proteins are not detectable in untreated adipocytes, whereas long-term exposure to 1-15 mg/dl uric acid increased the amount of several nitrosylated proteins starting with the lowest tested concentration (Fig. 8a , bands 1-5) to detectable levels.
Treatment of adipocytes with uric acid for 30 min increased nitrosylation of the protein(s) (Fig. 8b) with the apparent molecular mass similar to the protein 2 detected after longterm stimulation with uric acid (Fig. 8a) . Cell pretreatment with N-acetyl-cysteine, MnTMPyP or apocynin prevented nitrosylation of this protein (Fig. 8b) . Thus, superoxide generation and active NADPH oxidase are responsible for uric acid-induced protein nitrosylation in adipocytes.
To test formation of oxidized lipids, we used the oxidation-sensitive fluorescent fatty acid analog C11-BODIPY 581/591 that accumulates in lipid-containing structures of the cell and shifts fluorescence from red to green upon lipid peroxidation (9, 47) . Green fluorescence of the probe as well as green/red fluorescence ratio gradually increased in untreated adipocytes, most likely because of high basal level of oxidants (Fig. 8c,d) . Uric acid induced a dramatic increase in green fluorescence of the probe almost immediately, and this increase continued for at least 45-60 min (Fig. 8c,d and Supplemental Fig. S4b) becoming visible after long-term treatment (Supplemental Fig. S4a ). This effect was completely blocked by MnTMPyP or apocynin (Fig. 8c,d ) demonstrating that lipid oxidation in response to uric acid was mediated by NOX-dependent superoxide.
Discussion
The presented study is the first demonstration that uric acid exerts direct effects in adipocytes with potentially very important implications for our understanding of causal factors of the metabolic syndrome. It also provides a possible explanation for the paradox, in which the chemical antioxidant urate is associated with diseases driven by oxidative stress. We demonstrate that, at least in adipocytes, the redox-dependent effects of uric acid are mediated not by the redox chemistry of the urate compound but by the activation of intracellular oxidant production via NADPH oxidase.
So far, direct effects of soluble uric acid were characterized mostly in vascular smooth muscle cells and endothelial cells. In VSMC, uric acid activates critical proinflammatory pathways (23, 24) and stimulates cell proliferation (25, 49) . In endothelial cells, uric acid decreases nitric oxide bioavailability (27, 30) and inhibits cell migration and proliferation, which are mediated in part by the expression of C-reactive protein (CRP) (27) .
We observed urate-induced NADPH oxidase-dependent augmentation of ROS production and downstream ROS-mediated effects in differentiated adipocytes but not in preadipocytes. Adipocyte differentiation itself, which is accompanied by lipid accumulation and expression of differentiation markers in 3T3-L1 cells, induced basal ROS production, confirming recent findings (13) . In addition, adipocyte differentiation enhanced the capacity of the adipocyte to uptake uric acid. Surprisingly, URAT1, previously considered as a kidney-specific urate transporter (39) , is expressed in adipocytes, and might be one of the transporters of uric acid in these cells. URAT1 is also expressed by the human vascular smooth muscle cell (48) . The observation that ROS production in response to uric acid and downstream redox-dependent effects are sensitive to blockade of urate transport with probenecid and benzbromarone suggest that entry of uric acid into the cell is required for these effects.
The long-term and short-term effects of uric acid are similar. We observed dosedependent effects of uric acid in our in vitro model of hyperuricemia in mouse adipocytes within a concentration range 1-15 mg/dl with distinct effects observed at concentrations as low as 1 mg/dl (60µM). Mice, like most mammals, have active uricase eliminating most produced uric acid. Humans are not able to maintain the level of uric acid lower than about 3 mg/dl (20) . Therefore, it is possible that the dose dependence of the effects of uric acid in human adipocytes will be different.
Uric acid induced activation of NADPH oxidase in crude homogenates and isolated microsomal membranes of adipocytes. Mechanisms of activation of NOX enzymes vary greatly depending on the spectrum of expressed isoforms and cytoplasmic regulators.
NOX1-NOX3 require the presence of p22phox on the membrane and are more or less dependent on cytoplasmic subunits p47phox, p67phox and p40phox, which translocate to the membrane and form with NOX and p22phox an active holoenzyme complex in response to cell stimulation (4, 32) . NOX4 is a p22phox-dependent enzyme but does not require cytoplasmic subunits (35) , and neither of these subunits is involved in the activation of NOX5 (4). Analysis of the mRNA expression for known isoforms of NADPH oxidase presented here revealed that differentiated adipocytes express NOX2, NOX3 and NOX4 as well as different types of cytosolic subunits including p67phox and p47phox, which can activate several NOX enzymes. mRNA for p22phox, an important stabilizer for most NADPH holoenzymes, and p40phox, which is involved together with p47phox in the binding of 3-phosphoinositol lipids (11, 38) , are also expressed in 3T3-L1 adipocytes at lower levels. Such a diversity in the expression of NOX isoforms can be explained by the homology of adipocytes with phagocytes (expression of gp91phox), embryonic origin of 3T3-L1 cells (expression of NOX3, which is abundant in fetal tissues (4, 32) ), and ubiquity of NOX4. These NOX isoforms can provide constitutive and stimulated ROS production in adipocytes, and different mechanisms might be involved in the activation of NADPH oxidase in response to stimulation. Our data on translocation of p67phox and p40phox in response to uric acid indicate the possibility of assembly of the classical phagocyte-type NADPH oxidase based on gp91phox or another NOX protein.
Since we observed an increase in the content of p40phox and because of the abundance of NOX4 in adipocytes, which is regulated predominantly at the level of transcription (4), the mechanisms underlying regulation of NOX expression is a promising topic for future experiments. The upstream signaling mechanism linking urate transport into the cell and formation of the active NOX complex in adipocytes remain largely unknown.
NOX-dependent superoxide generation in adipocytes induced in response to uric acid is associated with an increase in phosphorylation of p38 and Erk1/2, which can be blocked, at least partially, by scavengers of superoxide and inhibitors of NADPH oxidase. This indicates that redox-dependent signaling via cascades of MAP kinases mediates the effects of uric acid in adipocytes downstream from NADPH oxidase.
Activation of p38 and Erk1/2 in response to uric acid has been also shown in vascular smooth muscle cells (24, 56) .
Our results show that uric acid can increase oxidative stress in adipocytes such that local nitric oxide is inhibited and protein nitrosylation occurs. We detected an increase in the 3-nitrotyrosine content in several proteins in response to uric acid. The short-term effect of uric acid on the protein nitrosylation was blocked by antioxidants and inhibition of NADPH oxidase demonstrating that NOX-dependent superoxide overproduction was responsible for protein nitrosylation. 3-nitrotyrosine is a stable marker of reactive nitrogen species including peroxynitrite which forms in a rapid reaction between nitric oxide and superoxide with a near diffusion controlled rate (10) . Peroxynitrite might be especially deleterious for adipocytes because its diffusion rate in hydrophobic lipid environment is very high (29) . Uric acid, indeed, induced lipid peroxidation, which was also prevented by NOX inhibition and superoxide scavenging. In addition, it is known from previous studies that, in the hydrophobic environment, uric acid loses its antioxidant ability (40) . In the presence of lipid peroxides uric acid even becomes a strong prooxidant (3). Thus, the intracellular environment of adipocytes, which is predominantly hydrophobic and with high basal level of ROS, is largely unfavorable for manifestation of the antioxidant properties of uric acid, especially in the case of oxidants such as peroxynitrite. Moreover, uric acid induces intracellular production of superoxide via NOX followed by formation of ROS and lipid peroxidation, which may further potentiate the chemical prooxidant ability of urate.
The adipose tissue is a source of low-grade inflammation in obesity, and this process plays a major role in the development of insulin resistance and vasculopathy leading to type II diabetes and increasing cardiovascular risk (6, 57) . Obesity-associated oxidative stress in the adipose tissue has been recently recognized as a major causative factor for obesity-related inflammation and the metabolic syndrome (13) . Uric acid blood levels positively correlate with obesity and BMI (8, 37, 45) and predict the development of hyperinsulinemia, obesity, and type 2 diabetes (36, 43, 58) . Therefore, based on the data presented in this study, hyperuricemia as a persistent condition associated with obesity might be a very important factor contributing to obesity-related oxidative stress.
Our results support previous epidemiological studies and animal models of hyperuricemia which suggest an involvement of uric acid in the pathogenesis of the metabolic syndrome, and provide a possible molecular mechanism for this role based on the finding that soluble uric acid affects adipocytes directly by inducing NADPH oxidase-dependent oxidative stress. We suggest that hyperuricemia can be one of the causal factors inducing oxidative stress followed by a proinflammatory process and endocrine dysfunction in the adipose tissue and thereby contribute to the pathogenesis of the metabolic syndrome and cardiovascular disease. 
